Senseonics tops Q4 EPS estimates, misses sales expectations

Shares in Senseonics (NYSE:SENS) closed down -3% yesterday after the medical device maker met earnings expectations on Wall Street with its fourth quarter and full-year financial results, but narrowly missed sales estimates. The Germantown, Md.-based company posted a net loss of -$16.3 million, or -12¢ per share, on sales of $2.9 million for the 3 months ended […]

AbbVie’s Elagolix succeeds in second phase 3 uterine fibroid study

AbbVie, along with Neurocrine Biosciences, announced that the Phase 3 ELARIS UF-II study (M12-817) of elagolix met its primary endpoint.

Kiadis raises €23.4m to develop immunotherapy for GVHD

Kiadis Pharma has raised €23.4m of funding in a private placement of 2.6 million new shares, for developing a T-cell immunotherapy product to reduce Graft versus Host Disease (GVHD) in hematopoietic stem cell transplantations (HSCT).

FDA grants Merck’s Keytruda priority review for cervical cancer

Merck’s anti-PD-1 therapy Keytruda (pembrolizumab) has been granted priority review designation by the US Food and Drug Administration (FDA) for the treatment of advanced cervical cancer.

Exactech wins FDA nod for Equinoxe stemless shoulder

Exactech (NSDQ:EXAC) said yesterday it won FDA clearance for its Equinoxe stemless shoulder prosthesis designed to be compatible for use with the Equinoxe shoulder system. The Gainesville, Fla.-based company said the system is designed for anatomic total shoulder arthroplasty procedures and features a 3D porous structure and an incorporated bone cage for bone through-growth to increase biologic […]

Ortho dev Trilliant Surgical raises $5m

Orthopedic device developer Trilliant Surgical has raised $5 million in a new round of equity financing, according to a recently posted SEC filing. Money in the round came from a single anonymous investor, with the date of the first sale noted on February 27, according to the filing. The Houston, Texas-based company, founded in 2007, […]

FDA warns of imaging issues associated with neurovascular coils

The FDA warned this week that neurovascular embolization coils may increase image artifact when magnetic resonance angiography imaging is used to image a patient’s aneurysm after coiling. Physicians use neurovascular embolization coils to treat brain aneurysms and often perform follow-up imaging after the procedure. Traditionally, doctors use digital subtraction angiography to image aneurysms after coiling, […]

Medartis IPO funds slated to support expansion

Swiss medtech company Medartis is reportedly planning to expand into the U.S. market and continue investing in Germany with the funds from its recently-announced initial public offering. Medartis announced yesterday that its IPO could include up to 2.84 million new shares of common stock priced at 44 – 54 Swiss francs apiece. That would generate […]

Hill-Rom to sell 3rd party rental biz to Universal Hospital Services

Hill-Rom Holdings (NYSE:HRC) said today it inked a deal to sell its third-party rental business to Minneapolis, Minn.-based Universal Hospital Services for an undisclosed amount. Under the deal, which is expected to close during Hill-Rom’s fiscal third quarter, Hill-Rom will transfer certain moveable medical equipment to UHS to be rented to customers. The third-party rental business […]

Invuity prez & CEO Sawyer steps down, Flora in as interim | Personnel Moves – March 13, 2018

Invuity (NSDQ:IVTY) said late last week that its president and chief executive officer Philip Sawyer has resigned and will be replaced by board member Scott Flora on an interim basis. Flora has served as a member of the board since last November, and has held positions as prez, CEO and director of Omniguide. He has also held […]